Different immune cells subpopulations are involved in the response triggered by these therapeutic agents, mainly represented by T reg, CD8 and CD4 T cells [4,5], but recent studies have shown that also NK cells actively participate in the successful outcome of anti-cancer treatment [12,13,14,15]. This evidence concerns the gene CD8A and cancer.